Clinical Trials | November 11, 2021
LifeCell Diagnostics expands newborn screening portfolio
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
New treatment options are critical, as approximately half of all people with heart failure die within five years of diagnosis. Heart failure accounts for more than one million hospitalisations a year in the US
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
Subscribe To Our Newsletter & Stay Updated
